Effects of e-cigarettes versus nicotine replacement therapy on short-term smoking abstinence when delivered at a community pharmacy

Cox, Sharon; Dawkins, Lynne; Doshi, Jay; Cameron, James M.

doi:10.1016/j.abrep.2019.100202

Cited by 17 publications

(10 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, satisfaction with e-liquid formulations containing nicotine might be limited by sensorial aspects, as nicotine content and flavour strength seem to correlate with harshness or throat irritation and perception of bitterness (51). Together, these findings could explain the results from some studies suggesting that ECs are more successful than NRT in providing smokers a satisfactory alternative to cigarettes (211,212). Table 3 summarises some of the findings from Pharmacokinetic studies according to EC type/generation.…”

Section: Nicotine Pharmacokinetic Studiesmentioning

confidence: 99%

Evidence From the Scientific Assessment of Electronic Cigarettes and Their Role in Tobacco Harm Reduction

Camacho

Ebajemito

Coburn

et al. 2021

Contributions to Tobacco &Amp; Nicotine Research

View full text Add to dashboard Cite

Summary While smoking remains a main global cause of preventable morbidity and mortality, a potential inflection point has arrived where it could become possible for non-combustible nicotine products to displace cigarettes and reduce risk for smokers who transition completely from smoking. These have proven consumer satisfaction and are now widely and increasingly available globally. One of the most prominent of these nicotine products are electronic cigarettes (ECs), which are used daily by millions of current and former smokers. The category is not without controversy as these products are not risk free and can cause nicotine dependence. The differing interpretation of science assessing ECs has transpired into inconsistent regulation and product standards, providing an environment for its fragmented manufacturing base which allows for variable product quality and in turn, product quality variability has impacted on how they are viewed. In this review, we assess published scientific evidence to evaluate whether, on balance, ECs fulfil a tobacco harm reduction role by reducing health risks relative to smoking and providing a viable alternative for smokers while having limited appeal to non-smokers.

show abstract

Section: Nicotine Pharmacokinetic Studiesmentioning

confidence: 99%

Evidence From the Scientific Assessment of Electronic Cigarettes and Their Role in Tobacco Harm Reduction

Camacho

Ebajemito

Coburn

et al. 2021

Contributions to Tobacco &Amp; Nicotine Research

View full text Add to dashboard Cite

show abstract

“…Under the most recent community pharmacy contracts [1,2], pharmacists in the UK, as in other countries internationally, are increasingly providing more clinically orientated services that focus on enhancing patient care. These extended roles include a wide range of services such as chronic disease and therapy management [3,4], diagnosis and treatment for minor ailments [5][6][7], independent prescribing [8,9], as well as health promotion activities such as smoking cessation [10,11], sexual health [12,13] and drug addiction services [14,15], weight management and healthy lifestyle support [16][17][18], immunizations including for flu [19] and COVID 19 [20], and travel health [21].…”

Section: Introductionmentioning

confidence: 99%

Will the Public Engage with New Pharmacy Roles? Assessing Future Uptake of a Community Pharmacy Health Check Using a Discrete Choice Experiment

Chua

Bond

Porteous

et al. 2022

Patient

View full text Add to dashboard Cite

Background Pharmacists are increasingly providing more clinically orientated services that focus on enhancing patient care and health promotion. However, little is known about how acceptable this is to the public. This study explored public preferences for a community pharmacy-based health check for cardiovascular disease (CVD). Methods A convenience sample of 423 individuals was recruited (from a community pharmacy, a dental practice, a shopping centre, a university campus and a sports centre) to complete a discrete choice experiment (DCE) survey administered face to face on a tablet. The DCE included six attributes: day of the week (weekday or weekends); way of accessing the service (walk-in and wait or by appointment); provider of health check (trainee pharmacist, pharmacist or nurse); duration of health check (30 or 45 min); follow-up phone call (no, yes and within 3 months); and cost (included to estimate the monetary value of health checks). Experimental design methods were used to create 12 choice tasks describing different health check services. Mixed logit (MXL) was used to analyse response data. Results Respondents had a preference for a community pharmacy-based CVD health check over no health check. They preferred a service provided (i) at the weekend; (ii) by appointment; (iii) by a nurse; (iv) for 30 min and (v) with follow-up after 3 months. Respondents were willing to pay £50 for this health check. Conclusion Findings affirm the public’s acceptance and value of a pharmacy-led CVD health check. The findings can inform pharmacy-based screening services before they are introduced, guide new service design and support resource allocation decisions. Supplementary Information The online version contains supplementary material available at 10.1007/s40271-021-00566-4.

show abstract

“…Pharmacy staff provide health promotion advice in the UK and sell e-cigarettes on retail pharmacy premises. 53 , 54 Hence, the views of pharmacists, pharmacy staff and pre-registered pharmacists on this topic is important to consider. Healthcare professionals (eg, doctors, nurses, pharmacists, etc.)…”

Section: Introductionmentioning

confidence: 99%

An Evaluation of the Knowledge and Perceptions of Pharmacy Staff and Pre-Registration Students of E-Cigarettes Use: A Systematic Review

Barrett

Aldamkhi

2021

Tob Use Insights

View full text Add to dashboard Cite

Introduction: Pharmacy staff are a trusted source of advice on the safe and appropriate use of medicines and devices. Retail pharmacies deliver smoking cessation services and sell e-cigarettes in the UK. This review asks ‘what knowledge, experience and ability do staff have to support e-cigarette users to quit smoking’. Methods: A systematic literature search was undertaken drawn on predefined eligibility criteria and a comprehensive search strategy following the PRISMA guideline. Eligible papers reported survey-research published in English from 2015 to 2020. PubMed, Google Scholar, OVID, EMBASE and MEDLINE Databases were searched. No restrictions on study design or language were applied. Two reviewers independently screened for inclusion/exclusion and then extracted the relevant information from the articles for synthesis. Results: Of 12 potentially eligible full-text studies, 1 was a duplicate, 7 were excluded as per eligibility criteria. Four papers were finally included in this literature review. Two studies indicated that pharmacy staff are less confident in giving advice on e-cigarette use. Knowledge on the adverse effects of e-cigarettes compared to traditional smoking cessation aids remain unclear. In one study, 42% of community pharmacists did not believe that e-cigarettes could be used for smoking cessation. Three studies identified need for specific regulations and professional support. The overall certainty of the evidence is ‘low’ or ‘very low’, with moderate levels of bias. Conclusion: Pharmacists may be well placed to implement e-cigarette smoking cessation interventions, but most practitioners lacked knowledge and ability to support these customers citing unclear risk of harm. Pharmacists felt secure in recommending traditional cessation tools. Further regulation, guidelines and training is needed. Findings may be less generalizable in countries where e-cigarettes are banned. Their extent of knowledge, experience and ability to support users of e-cigarettes within their community to quit smoking is lacking.

show abstract

Effects of e-cigarettes versus nicotine replacement therapy on short-term smoking abstinence when delivered at a community pharmacy

Cited by 17 publications

References 6 publications

Evidence From the Scientific Assessment of Electronic Cigarettes and Their Role in Tobacco Harm Reduction

Evidence From the Scientific Assessment of Electronic Cigarettes and Their Role in Tobacco Harm Reduction

Will the Public Engage with New Pharmacy Roles? Assessing Future Uptake of a Community Pharmacy Health Check Using a Discrete Choice Experiment

An Evaluation of the Knowledge and Perceptions of Pharmacy Staff and Pre-Registration Students of E-Cigarettes Use: A Systematic Review

Contact Info

Product

Resources

About